Reuters logo
BRIEF-Vanda Pharma jumps in premarket after drug for rare disorder meets main trial goal
December 18, 2012 / 1:15 PM / 5 years ago

BRIEF-Vanda Pharma jumps in premarket after drug for rare disorder meets main trial goal

NEW YORK, Dec 18 (Reuters) - Vanda Pharmaceuticals Inc : * Pharma jumps 30.1 percent to $4.19 in premarket after drug for non-24-hour disorder, which affects blind people, met the main goal of showing improvement over a placebo

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below